Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 2/20 | 0.38 |
| ▸ | ACSS2 | Q9NR19 | 1/20 | 0.36 |
| ▸ | SYK | P43405 | 1/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.36 |
| ▸ | RORC | P51449 | 3/20 | 0.35 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.35 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.35 |
| ▸ | MAPKAPK2 | P49137 | 2/20 | 0.34 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.34 |
| ▸ | GLS | O94925 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27240244 | 0.78 | GRM5 (0.42) | GRM5ACSS2SYKRORCMEN1 | |
| SCHEMBL29827331 | 0.78 | GRM5 (0.42) | GRM5SYKMAPKAPK2EGFRAURKB | |
| SCHEMBL23273849 | 0.78 | GRM5 (0.42) | GRM5SYKMAPKAPK2EGFRAURKB | |
| SCHEMBL27240040 | 0.76 | GRM5 (0.41) | GRM5RORCMEN1LMNAKMT2A | |
| SCHEMBL23288026 | 0.75 | GRM5 (0.44) | GRM5RORCMAPKAPK2 | |
| SCHEMBL27240202 | 0.75 | GRM5 (0.41) | GRM5MAPKAPK2MEN1LMNAKMT2A | |
| SCHEMBL27240046 | 0.74 | MEN1 (0.40) | GRM5MAPKAPK2MEN1LMNAKMT2A | |
| SCHEMBL23287990 | 0.73 | MEN1 (0.39) | GRM5MEN1LMNAKMT2ASMN1; SMN2 | |
| SCHEMBL27240259 | 0.73 | GRM5 (0.38) | GRM5RORCMEN1LMNAKMT2A | |
| SCHEMBL27240067 | 0.72 | LCK (0.41) | GRM5MEN1LMNAKMT2ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021080013-A1 | INHIBITORS OF TREK (TWIK RELATED K+ CHANNELS) CHANNEL FUNCTION | ONO PHARMACEUTICAL CO., LTD. (JP) | 2021-04-29 | — | — | WO | disclosed |